Small Doses: Pharmacy News Featuring Opioids, Ketamine, and More Small Doses is news for pharmacists in a way that works for you. Pharmacists to Descend on Washington March 24, 2017 By Christine Blank DIR fees and health-care reform will lead pharmacists’ legislative concerns. Four ways Medicare Part D has affected costs for diabetic patients November 22, 2016 By Tracey Walker Understand Medicare Part D’s design and its coverage gap to offer the most affordable prescription drug options for patients. Drug costs chief concern of Medicare recipients November 03, 2016 By Christine Blank Medicare Part D recipients are most concerned about prescription drug costs—and their co-pay costs are the most important factor when choosing a pharmacy. Medicare Part D patients not taking blood pressure meds correctly September 20, 2016 By Tracey Walker Expert offers specific actions for managed care execs to take Every pharmacist has them — and so does every teacher August 10, 2016 By David Stanley RPh What do pharmacists and teachers — and an awful lot of other people — have in common? Medicare drug pricing debate heats up August 03, 2016 By Christine Blank A senator is investigating whether Medicare's prescription drug benefit is vulnerable to manipulation by pharmaceutical companies after an exclusive Associated Press report showed that Medicare’s spending on certain drugs soared by 85 percent. Medicare drug costs should parallel those of Medicaid Medicare should have the same authority that Medicaid has to negotiate drug prices directly with manufacturers. If the government can do it for one program, it can do it for another. How Walmart plans to save on generics June 03, 2016 By Christine Blank Walmart has decided to put all its eggs in a really big basket. Biosimilars pose problems for Medicare beneficiaries April 25, 2016 By Christine Blank Surprisingly, Medicare beneficiaries are likely to pay much more for biosimilars than the referenced brand medication, according to a new report.